Capricor Therapeutics Inc (CAPR)
5.68
+0.13
(+2.34%)
USD |
NASDAQ |
May 31, 16:00
5.70
+0.02
(+0.35%)
After-Hours: 20:00
Capricor Therapeutics Cash from Operations (Quarterly): -1.268M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -1.268M |
| December 31, 2023 | -11.59M |
| September 30, 2023 | -8.795M |
| June 30, 2023 | -9.418M |
| March 31, 2023 | 4.210M |
| December 31, 2022 | -6.902M |
| September 30, 2022 | -5.686M |
| June 30, 2022 | -6.542M |
| March 31, 2022 | 24.05M |
| December 31, 2021 | -5.628M |
| September 30, 2021 | -3.338M |
| June 30, 2021 | -4.514M |
| March 31, 2021 | -3.329M |
| December 31, 2020 | -3.842M |
| September 30, 2020 | -2.978M |
| June 30, 2020 | -2.017M |
| March 31, 2020 | -1.218M |
| December 31, 2019 | -1.785M |
| September 30, 2019 | -1.651M |
| June 30, 2019 | -1.777M |
| March 31, 2019 | -1.608M |
| December 31, 2018 | -3.771M |
| September 30, 2018 | -2.982M |
| June 30, 2018 | -3.691M |
| March 31, 2018 | -3.418M |
| Date | Value |
|---|---|
| December 31, 2017 | -2.667M |
| September 30, 2017 | -3.190M |
| June 30, 2017 | -3.698M |
| March 31, 2017 | -4.676M |
| December 31, 2016 | -3.478M |
| September 30, 2016 | -1.912M |
| June 30, 2016 | -4.884M |
| March 31, 2016 | -4.181M |
| December 31, 2015 | -3.643M |
| September 30, 2015 | -3.245M |
| June 30, 2015 | -1.878M |
| March 31, 2015 | -2.052M |
| December 31, 2014 | -2.146M |
| September 30, 2014 | -2.222M |
| June 30, 2014 | -6.016M |
| March 31, 2014 | 11.34M |
| December 31, 2013 | 0.1798M |
| September 30, 2013 | -4.512M |
| June 30, 2013 | -0.6357M |
| March 31, 2013 | -1.176M |
| December 31, 2012 | -0.1118M |
| September 30, 2012 | -0.4947M |
| June 30, 2012 | -0.8528M |
| March 31, 2012 | -0.6035M |
| December 31, 2011 | -1.569M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-11.59M
Minimum
Dec 2023
24.05M
Maximum
Mar 2022
-2.701M
Average
-3.334M
Median
Cash from Operations (Quarterly) Benchmarks
| Sarepta Therapeutics Inc | -242.08M |
| PTC Therapeutics Inc | 70.76M |
| Solid Biosciences Inc | -25.19M |
| Inovio Pharmaceuticals Inc | -28.76M |
| Stereotaxis Inc | -2.346M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -9.502M |
| Cash from Financing (Quarterly) | 2.290M |
| Free Cash Flow | -33.33M |
| Free Cash Flow Per Share (Quarterly) | -0.0616 |
| Free Cash Flow to Equity (Quarterly) | -1.933M |
| Free Cash Flow Yield | -20.73% |